Director William H. Milliken was quoted in the article “SCOTUS Limits Patent Judges’ Power but Preserves PTAB Review,” published by MedCity News. He commented on the US Supreme Court’s decision in United States v. Arthrex, Inc. that was issued on June 21, 2021. From the article:

“‘I expect the director will have the opportunity to decide whether to rehear a number of other cases that were previously remanded to the PTAB and stayed (which had left the status of those patents in limbo pending a decision in Arthrex),’ said William H. Milliken, a director at Sterne, Kessler, Goldstein & Fox who issued the firm’s client alert on the case. ‘However, the mechanics of this review process remain to be seen.'”